Discover more insights into Novel P2y12 소설 P2y12

Keywords frequently search together with Novel P2y12 소설 P2y12

Narrow sentence examples with built-in keyword filters

Novel P2y12 sentence examples within novel p2y12 receptor



Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.


Erratum to: CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

Novel P2y12 sentence examples within novel p2y12 inhibitor



Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Controlled Trials.


Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond.

Novel P2y12 sentence examples within novel p2y12 antagonist



Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study


Impact of morphine use on mortality in STEMI patients treated with primary PCI - preliminary data from a new registry


Learn more from Novel P2y12 소설 P2y12



Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-analysis of Randomized Controlled Trials.



Insights from In Vitro and Clinical Data to Guide Transition from the Novel P2Y12 Antagonist Selatogrel to Clopidogrel, Prasugrel, and Ticagrelor.



Aspirin-free antiplatelet regimens after PCI: insights from the GLOBAL LEADERS trial and beyond.



Erratum to: CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure



Ticagrelor versus Clopidogrel in the Dual Antiplatelet Regimen for Intracranial Stenting or Flow-Diverter Treatment for Unruptured Cerebral Aneurysms: A Single-Center Cohort Study



Impact of morphine use on mortality in STEMI patients treated with primary PCI - preliminary data from a new registry



De-Escalation of Treatment With Oral P2Y12 Receptor Inhibitors: Current Status and Perspectives



Pharmacodynamic assessment of prasugrel and clopidogrel in patients with non-cardioembolic stroke: a multicenter, randomized, active-control clinical trial



Impact of anemia as risk factor for major bleeding and mortality in patients with acute coronary syndrome.



Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes



Chronic Kidney Disease and Third‐Generation P2Y12 Inhibitors Use in Patients With Acute Coronary Syndrome: Impact on the Prognosis at 1 Year


More Novel P2y12 소설 P2y12 sentence examples
10.1080/14656566.2019.1615329

Bivalirudin infusion in patients with acute coronary syndrome after stenting



Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry.


Learn more from Novel P2y12 소설 P2y12

Novel P2y12 소설 P2y12


Novel P2y12 소설 P2y12
Encyclopedia 백과사전